...
首页> 外文期刊>Lab Asia >Recombinant Antibodies for In Vivo Research Launched
【24h】

Recombinant Antibodies for In Vivo Research Launched

机译:启动了体内研究的重组抗体

获取原文
获取原文并翻译 | 示例
           

摘要

Absolute Antibody Ltd has announced the launch of its VivopureX~TM recombinant mouse antibodies for in vivoresearch in mouse models.The collection consists of popular antibody clones,many originally obtained from rats or hamsters,which Absolute Antibody has engineered into mouse-anti-mouse recombinant versions to improve research results.The antibodies are all available in discounted bulk sizes ranging from 1 mg to 100 mg.VivopureX~TM antibodies are species-matched chimeric antibodies,consisting of a clone's original antigen-binding variable domain with a mouse constant domain,which means they do not induce neutralising antibodies in mouse models.As a result,the engineered recombinant antibodies offer many advantages compared to the original monoclonal antibodies,including increased long-term efficacy,stronger potency and a more consistent response across cohorts.In addition,VivopureX~TM antibodies feature engineered effector functions,with Fc receptor binding tailored to best suit popular applications such as depletion,agonism or blocking.
机译:绝对抗体有限公司已宣布发射其Vivopurex〜tm重组小鼠抗体,用于鼠标型中的VivoreEarch。该系列由流行的抗体克隆组成,许多抗体克隆最初是从大鼠或仓鼠中获得的,绝对是从大鼠或仓鼠中获得的,绝对已在其中进行了鼠标 - 抗体的工程,以使鼠标抗体重新组合中的小鼠抗体重组组成可以改善研究结果的版本。抗体均以1毫克至100 mg的折扣大小可用。Vivopurex〜TM抗体是物种匹配的嵌合抗体,由克隆的原始抗原结合域和小鼠零件域,小鼠固定域,小鼠固定域组成这意味着它们不会在小鼠模型中诱导中和抗体。因此,与原始的单克隆抗体相比,工程化的重组抗体具有许多优势,包括增加长期疗效,更强的效力和更加一致的响应。 Vivopurex〜TM抗体具有工程效应器功能,FC受体结合量身定制为最佳西装流行ULAR应用,例如耗竭,激动剂或阻塞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号